Want to see TSE:CRRX full AI Analyst Report?

CareRx (CRRX) Price & Analysis

82 Followers

CRRX Stock Chart & Stats

C$3.79

C$0.05(2.33%)

At close: Jan 08 4:00 PM EST

C$3.79

C$0.05(2.33%)

Day’s Range― - ―

52-Week RangeC$2.70 - C$4.00

Previous CloseN/A

Volume3.32K

Average Volume (3M)71.09K

Market Cap

C$219.37M

Enterprise ValueC$264.57M

Total Cash (Recent Filing)C$15.32M

Total Debt (Recent Filing)C$78.13M

Price to Earnings (P/E)8.0

Beta0.18

Next Earnings

Aug 06, 2026

EPS Estimate

0.02

Next Dividend Ex-DateN/A

Dividend Yield1.03%

Share Statistics

EPS (TTM)0.43

Shares Outstanding63,453,266

10 Day Avg. Volume18,484

30 Day Avg. Volume71,092

Financial Highlights & Ratios

PEG Ratio-0.01

Price to Book (P/B)2.19

Price to Sales (P/S)0.65

P/FCF Ratio10.92

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

C$5.25

Price Target Upside38.52% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering3

EPS Forecast (FY)0.15

Revenue Forecast (FY)C$385.01M

Bulls Say, Bears Say

Bulls Say

Balance Sheet And AcquisitionsA strong balance sheet provides capacity to pursue acquisitions, offering a clear path to accelerate growth when attractive targets emerge.

Margins And EfficiencyAutomation and economies of scale are reducing labor required per bed, supporting margin expansion as the business scales.

RevenueRevenue beat analyst expectations, driven by higher revenue per bed that offset lower volumes and signaled stronger-than-anticipated sales performance.

Bears Say

Cost PressuresHigher-than-expected general and administrative costs from inflation are pressuring operating profits and may compress margins if cost inflation persists.

Operational VolumeThe number of beds serviced was slightly below analyst expectations, reflecting weaker operational volume that could slow revenue momentum.

CareRx News

CareRx Maintained at Buy as Analyst Trims Price Target to $5 on Near-Term Headwinds but Sees Upside Potential

CareRx, the Healthcare sector company, was revisited by a Wall Street analyst on May 8. Analyst David Martin...

2M ago

Carerx Earnings Call Signals Profitable Growth Momentum

Carerx Corporation (($TSE:CRRX)) has held its Q4 earnings call. Read on for the main highlights of the call....

4M ago

CareRx: Improving Unit Economics and Tuck‑In Growth Pipeline Support Buy Rating

Bloom Burton analyst David Martin PhD has maintained their bullish stance on CRRX stock, giving a Buy rating...

4M ago

CareRx Declares Q1 2026 Dividend Amid Stable Seniors Pharmacy Operations

CareRx ( ($TSE:CRRX) ) has issued an update. CareRx Corporation has declared a quarterly dividend of CAD$0.02 per...

4M ago

CareRx Posts First Full-Year Profit, Boosts Margins and Launches Dividend in 2025

An announcement from CareRx ( ($TSE:CRRX) ) is now available. CareRx reported 2025 revenue of $370.2 million, modestly...

4M ago

Carerx Corporation (CRRX) Q4 Earnings Cheat Sheet

Carerx Corporation (CRRX) is scheduled to report 4th quarter earnings on 03/04/2026, after the market closes. Regarding Q4...

4M ago

CareRx Sets Date to Release 2025 Results and Host Investor Call

The latest update is out from CareRx ( ($TSE:CRRX) ). CareRx Corporation, a national provider of pharmacy services...

4M ago

CareRx downgraded to Speculative Buy from Buy at Cormark

Cormark analyst Kyle McPhee downgraded CareRx (CHHHF) to Speculative Buy from Buy with a C$4.50 price target Published...

6M ago

CareRx Declares Q4 2025 Dividend, Reinforcing Shareholder Value

CareRx ( ($TSE:CRRX) ) has provided an announcement. CareRx Corporation has announced a dividend of CAD$0.02 per common...

7M ago

CareRx Earnings Call Highlights Robust Growth and Future Optimism

Carerx Corporation (($TSE:CRRX)) has held its Q3 earnings call. Read on for the main highlights of the call....

8M ago

CRRX FAQ

What was CareRx’s price range in the past 12 months?

CareRx lowest stock price was C$2.69 and its highest was C$4.00 in the past 12 months.

What is CareRx’s market cap?

CareRx’s market cap is C$219.37M.

When is CareRx’s upcoming earnings report date?

CareRx’s upcoming earnings report date is Aug 06, 2026 which is in 34 days.

How were CareRx’s earnings last quarter?

CareRx released its earnings results on May 06, 2026. The company reported C$0.02 earnings per share for the quarter, missing the consensus estimate of C$0.04 by -C$0.02.

Is CareRx overvalued?

According to Wall Street analysts CareRx’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does CareRx pay dividends?

CareRx pays a Quarterly dividend of C$0.02 which represents an annual dividend yield of 1.03%. See more information on CareRx dividends here

What is CareRx’s EPS estimate?

CareRx’s EPS estimate is 0.02.

How many shares outstanding does CareRx have?

CareRx has 63,453,266 shares outstanding.

What happened to CareRx’s price movement after its last earnings report?

CareRx reported an EPS of C$0.02 in its last earnings report, missing expectations of C$0.04. Following the earnings report the stock price went down -2.997%.

Which hedge fund is a major shareholder of CareRx?

Currently, no hedge funds are holding shares in TSE:CRRX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

CareRx Stock Smart Score

Neutral

Analyst Consensus

Strong Buy

Average Price Target:
C$5.25 (38.52% Upside)

Technicals

Fundamentals

Return on Equity

27.47%

Trailing 12-Months

Asset Growth

11.32%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

CareRx

CareRx Corporation, operating with its subsidiaries, specializes in delivering tailored pharmaceutical services to Canada's senior demographic. The company manages a vast network of medication dispensing facilities, which are responsible for providing chronic prescriptions and a variety of other advanced clinical pharmacy solutions. Currently, it caters to approximately 50,000 individuals residing in roughly 900 distinct senior and communal living environments, including extended care residences, retirement communities, supportive living facilities, and group homes. Founded in 2001 and based in Toronto, Canada, the corporation rebranded as CareRx Corporation in June 2020, having formerly been known as Centric Health Corporation.

CareRx (CRRX) Earnings & Revenues

Historic Earnings Reports

CRRX Stock 12 Month Forecast

Average Price Target

C$5.25

▲(38.52% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"C$1","4":"C$4","7":"C$7","2.5":"C$2.5","5.5":"C$5.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":6.25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">C$6.25</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">C$5.25</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">C$4.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,2.5,4,5.5,7],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.16,3.397692307692308,3.6353846153846154,3.873076923076923,4.110769230769231,4.348461538461539,4.586153846153846,4.823846153846154,5.061538461538461,5.299230769230769,5.5369230769230775,5.774615384615385,6.012307692307692,{"y":6.25,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.16,3.3207692307692307,3.4815384615384617,3.6423076923076922,3.8030769230769232,3.963846153846154,4.124615384615384,4.285384615384615,4.446153846153846,4.606923076923077,4.7676923076923075,4.928461538461539,5.089230769230769,{"y":5.25,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.16,3.263076923076923,3.3661538461538463,3.4692307692307693,3.5723076923076924,3.6753846153846155,3.7784615384615385,3.8815384615384616,3.9846153846153847,4.087692307692308,4.190769230769231,4.293846153846154,4.396923076923077,{"y":4.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.689,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.845,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.767,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.923,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.383,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.53,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.442,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.776,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.835,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.815,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.597,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.667,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.16,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >